0001250853-18-000112.txt : 20180808
0001250853-18-000112.hdr.sgml : 20180808
20180808181047
ACCESSION NUMBER: 0001250853-18-000112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180806
FILED AS OF DATE: 20180808
DATE AS OF CHANGE: 20180808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EDDLEMAN ROY T
CENTRAL INDEX KEY: 0001270264
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 181002715
MAIL ADDRESS:
STREET 1: 110 W. GEORGE BURNS ROAD
STREET 2: SUITE D-4018
CITY: LOS ANGELES
STATE: CA
ZIP: 90048
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-08-06
0
0000730272
REPLIGEN CORP
RGEN
0001270264
EDDLEMAN ROY T
1801 CENTURY PARK E.
16TH FLOOR
LOS ANGELES
CA
90067
0
0
1
0
Common stock
2018-08-06
4
S
0
33142
49.0495
D
796858
I
As trustee
Common stock
2018-08-07
4
S
0
16015
49.0526
D
413985
D
Common stock
2018-08-08
4
S
0
4770
49.0504
D
409215
I
As trustee
Common stock
2903446
I
As trustee
Common stock
357518
D
The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $49.207 to $49.1358, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price with the price ranges set forth in this footnote and in footnote (3), below.
The shares shown are held, of record, by a charitable remainder unitrust of which the reporting person is the sole trustee and, as such, has investment and voting control over such shares, and is a lifetime beneficiary. The reporting person disclaims as beneficial ownership of the shares except to the extent of his pecuniary interest therein.
The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $49.0500 to $49.0908, inclusive.
The shares shown are held, of record, by a second charitable remainder unitrust of which the reporting person is the sole trustee and, as such, has investment and voting control over such shares, and is a lifetime beneficiary. The reporting person disclaims as beneficial ownership of the shares except to the extent of his pecuniary interest therein.
The shares shown are held of record by the Roy T. Eddleman Living Trust UAD 8-7-2000, of which the reporting person is the sole trustee, and as such, has investment and voting control over such shares.
The shares shown are held for the benefit of the reporting person in a 15-month escrow account established in connection with the acquisition of Spectrum, Inc. by the issuer on August 1, 2017 and are subject to potential indemnification claims of the issuer relating to the acquisition.
Istvan Benko, as Attorney-in-Fact for Roy T. Eddleman
2018-08-08